- Home
- ICU vs NXGL Comparison
ICU vs NXGL Comparison
Compare ICU & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICU | NXGL |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 15.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICU | NXGL |
|---|---|---|
| Price | $0.26 | $1.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 82.4K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $881,000.00 | ★ $11,666,000.00 |
| Revenue This Year | $691.85 | $39.28 |
| Revenue Next Year | $64.17 | $42.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1195.59 | 73.37 |
| 52 Week Low | $0.22 | $1.45 |
| 52 Week High | $3.07 | $4.95 |
Technical Indicators
Market Signals| Indicator | ICU | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 35.81 | 41.10 |
| Support Level | $0.22 | $1.55 |
| Resistance Level | $0.28 | $1.90 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 25.29 | 14.02 |
Price Performance
Historical ComparisonAbout ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.